Catalyst Wire Dossier Catalyst Wire Dossier

Norflo Oro

· Eye Pharma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Norflo Oro, covering 2022-03-28 to 2022-03-28. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of the Anti-inflammatory Effects of Norflo Oro in Acute Relapses of HLA-B27 Associated Autoimmune Uveitis [EARLY_Phase 1]

See pricing